发明名称 FORMULATION
摘要 The present invention relates to a CRH formulation having improved stability/efficacy. The improved CRH formulation is particularly suitable for treatment of various disorders. The invention also relates to a method of producing the CRH formulation, and to methods of treatment using said CRH formulation.
申请公布号 US2013344102(A1) 申请公布日期 2013.12.26
申请号 US201313836547 申请日期 2013.03.15
申请人 AIMSCO LIMITED 发明人 SHOTTON DAVID JOHN;HAQ SYED EBADAT;MCINTOSH DEIRDRE PATRICIA
分类号 A61K38/22;A61K38/01;A61K38/33;A61K38/34;A61K45/06 主分类号 A61K38/22
代理机构 代理人
主权项
地址